neptra
bayer animal health gmbh - florfenicol, terbinafine hidroklorid, mometasone furoate - otologicals, kortikosteroidi in antiinfectives v kombinaciji - psi - za zdravljenje akutnih udarci otitis externa ali akutno exacerbations ponavljajočih se otitis, ki jih povzročajo mešane okužbe dovzetni sevov bakterije občutljive za florfenicol (staphylococcus pseudintermedius) in gliv, občutljiv na terbinafine (malassezia pachydermatis).
5-fluorouracil ebewe 50 mg/ml koncentrat za raztopino za injiciranje ali infundiranje
ebewe pharma - fluorouracil - koncentrat za raztopino za injiciranje/infundiranje - fluorouracil 50 mg / 1 ml - fluorouracil
onureg
bristol-myers squibb pharma eeig - azacitidin - leukemija, myeloid, akutna - antineoplastična sredstva - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).
nasivin 0,5 mg/ml pršilo za nos, raztopina
merck selbstmedikation gmbh - oksimetazolin - pršilo za nos, raztopina - oksimetazolin 0,44 mg / 1 ml - oksimetazolin
nasivin brez konzervansov 0,5 mg/ml pršilo za nos, raztopina
merck selbstmedikation gmbh - oksimetazolin - pršilo za nos, raztopina - oksimetazolin 0,44 mg / 1 ml - oksimetazolin
nasic za otroke 0,5 mg/50 mg v 1 ml pršilo za nos, raztopina
cassella-med gmbh & co. kg - dekspantenol; ksilometazolin - pršilo za nos, raztopina - dekspantenol 50 mg / 1 ml ksilometazolin0,43 mg / 1 ml; ksilometazolin 0,43 mg / 1 ml - ksilometazolin
nasic za otroke 0,5 mg/50 mg v 1 ml pršilo za nos, raztopina
cassella-med gmbh & co. kg - dekspantenol; ksilometazolin - pršilo za nos, raztopina - dekspantenol 50 mg / 1 ml ksilometazolin0,43 mg / 1 ml; ksilometazolin 0,43 mg / 1 ml - ksilometazolin
nasic 1 mg/50 mg v 1 ml pršilo za nos, raztopina
cassella-med gmbh & co. kg - dekspantenol; ksilometazolin - pršilo za nos, raztopina - dekspantenol 50 mg / 1 ml ksilometazolin0,87 mg / 1 ml; ksilometazolin 0,87 mg / 1 ml - ksilometazolin
nasic 1 mg/50 mg v 1 ml pršilo za nos, raztopina
cassella-med gmbh & co. kg - dekspantenol, ksilometazolin - pršilo za nos, raztopina - dekspantenol 50 mg / 1 ml; ksilometazolin 0,87 mg / 1 ml - ksilometazolin
menquadfi
sanofi pasteur - neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid - meningitis, meningokokni - cepiva - menquadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w, and y. the use of this vaccine should be in accordance with available official recommendations.